Clinical trials
Dementia trials in Sweden
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
40 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2004 | 2 |
| 2005 | 1 |
| 2006 | 1 |
| 2007 | 2 |
| 2009 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2015 | 2 |
| 2016 | 1 |
| 2017 | 3 |
| 2018 | 4 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 7 |
| 2024 | 4 |
| 2025 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 14 |
| Recruiting | 8 |
| Active, not recruiting | 6 |
| Terminated | 5 |
| Unknown status | 4 |
| Withdrawn | 2 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Karolinska Institutet | 3 |
| Novartis Pharmaceuticals | 3 |
| Region Skane | 3 |
| Umeå University | 3 |
| GlaxoSmithKline | 2 |
| Janssen Research & Development, LLC | 2 |
| Region Örebro County | 2 |
| AC Immune SA | 1 |
| Aarhus University Hospital | 1 |
| AbbVie | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Dementia | 40 |
| Alzheimer Disease | 22 |
| Cognitive Dysfunction | 16 |
| Brain Diseases | 7 |
| Central Nervous System Diseases | 5 |
| Neurodegenerative Diseases | 5 |
| Memory Disorders | 4 |
| Nervous System Diseases | 4 |
| Hydrocephalus, Normal Pressure | 3 |
| Pick Disease of the Brain | 3 |
Trials
Showing 1 to 25 of 40. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.